top of page

Our team brought Okapi Sciences from a series A in 2008 to a healthy acquisition in 2014. The same team has merged Okapi Sciences’ livestock assets with innovations at Academia to form ViroVet. Currently we are approaching 20 FTE. Our company was elected as 2015 and 2017 startup of the year by Animal Pharm News. You can meet and connect with our board members, the management, our advisors and our investors by clicking below.

Board of Directors

Management & Advisors

Investors

Erwin Blomsma

CEO ViroVet

CEO ViroVet
Ludwig Goris

for CSCF

for CSCF
Thomas Beke

for PMV

for PMV
Patrik Haesen

for AIF

for AIF
Laetitia Gerbe

for Seventure Partners

for Seventure Partners
Yannick Vancoppenolle

for VIVES

for VIVES
Ilse Sienaert

for GFF / KU Leuven

for GFF / KU Leuven
Erwin Blomsma

CEO & Co-Founder

CEO & Co-Founder
Nesya Goris

CDO & Co-Founder

CDO & Co-Founder
Stefaan Wera

COO & Co-Founder

COO & Co-Founder
Bart Crijns

Finance Director

Finance Director
George Gunn

Strategic Advisor

Strategic Advisor
AIF

Agri Investment Fund

PMV

Biotech Fonds Vlaanderen

CSCF

Capricorn Sustainable Chemistry Fund

GFF

Gemma Frisius Fund

VIVES

Louvain Technology Fund

Seventure Partners

AVF Fund

bottom of page